Comparison of non-Cochrane systematic reviews and their published protocols: differences occurred frequently but were seldom explained

To quantify the prevalence of differences in the reported methods between non-Cochrane systematic reviews (SRs) and their protocols and the extent to which these were reported and explained. We searched MEDLINE and Embase to identify protocols of non-Cochrane SRs published in 2012 and 2013. Using va...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of clinical epidemiology 2019-06, Vol.110, p.34-41
Hauptverfasser: Koensgen, Nadja, Rombey, Tanja, Allers, Katharina, Mathes, Tim, Hoffmann, Falk, Pieper, Dawid
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:To quantify the prevalence of differences in the reported methods between non-Cochrane systematic reviews (SRs) and their protocols and the extent to which these were reported and explained. We searched MEDLINE and Embase to identify protocols of non-Cochrane SRs published in 2012 and 2013. Using various methods, we searched for their corresponding SRs up to December 2016. The SRs and protocols were compared with respect to the methods-related “Preferred Reporting Items for Systematic review and Meta-Analysis Protocols” (PRISMA-P). We included 80 SRs and their protocols. Almost all SRs (92.5%) differed from their protocols in at least one of the methods-related PRISMA-P items (no. 7–17) and their subcategories. Half the SRs (48.8%) had a major difference in at least one item. On average, each SR differed from its protocol in 3.2 items, of which one comprised a major difference. Only 10% of all differences were reported in the SR, two-thirds with an explanation (7.0% in total). The reporting quality and transparency of non-Cochrane SRs requires further improvement. Authors should report and explain all important changes made to the protocol in the SR publication. The updated PRISMA statement should include guidance regarding this matter.
ISSN:0895-4356
1878-5921
DOI:10.1016/j.jclinepi.2019.02.012